The DOI matches its OpenAlex record.
Methotrexate for psoriasis. A new therapeutic schedule
Abstract
Therapy of patients with severe psoriasis has been facilitated in recent years by the use of systemic methotrexate. Several common schedules for drug administration include small daily oral doses and weekly intramuscular or oral doses. These schedules were empirically designed and have had reasonably good results. A new schedule of methotrexate administration is recommended for the treatment of psoriasis, based on current knowledge concerning the epidermal cell proliferation kinetics of psoriasis and chemotherapy with cell-cycle specific drugs. Methotrexate was administered orally in small doses (2.5 to 7.5 mg) at 12-hour intervals for a total of three doses at weekly intervals. Of 26 patients with severe psoriasis, 20 attained 75% to 100% improvement with administration of methotrexate. Side effects were minimal. The pharmacologic rationale for this drug schedule and its value relative to other commonly used schedules is discussed. Consideration of potential long-term risks with methotrexate must still be considered when evaluating patients for therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Guidelines of care for the management of psoriasis and psoriatic arthritis
Gottlieb, A., Korman, N. J., Gordon, K. B., Feldman, S. R., Lebwohl, M., Koo, J. Y. M., Van Voorhees, A. S., Elmets, C. A., Leonardi, C. L., Beutner, K. R., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.02.040 · Cited by 769
Pathirana, D., Ormerod, A., Saiag, P., Smith, C., Spuls, P., Nast, A., Barker, J., Bos, J., Burmester, G., Chimenti, S., et al. (2009) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2009.03389.x · Cited by 703
Guidelines of care for the management of psoriasis and psoriatic arthritis
Menter, A., Korman, N. J., Elmets, C. A., Feldman, S. R., Gelfand, J. M., Gordon, K. B., Gottlieb, A. B., Koo, J. Y. M., Lebwohl, M., Lim, H. W., et al. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.03.027 · Cited by 558
Greaves, M. W., & Weinstein, G. D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503023320907 · Cited by 512
Self-citationMethotrexate versus Cyclosporine in Moderate-to-Severe Chronic Plaque Psoriasis
Heydendael, V. M. R., Spuls, P. I., Opmeer, B. C., de Borgie, C. A. J. M., Reitsma, J. B., Goldschmidt, W. F. M., Bossuyt, P. M. M., Bos, J. D., & de Rie, M. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021359 · Cited by 475
Metadata
- Authors
- Weinstein, G. D.
- Venue
- Archives of Dermatology
- Publisher
- American Medical Association
- Published
- 1971-01-01
- Volume
- 103
- Issue
- 1
- Pages
- 33-38
- ISSN
- 0003-987X (ISSN-L)
- OpenAlex
- W4237026486
- Cited by
- 268
- References
- 0
- FWCI
- 4.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Methotrexate for psoriasis. A new therapeutic schedule. https://app.cochat.ai/papers/10.1001/archderm.103.1.33
- The paper
- Weinstein, G. D. (1971). Methotrexate for psoriasis. A new therapeutic schedule. Archives of Dermatology. https://doi.org/10.1001/archderm.103.1.33
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.